Study programme 2025-2026Français
Pharmacie clinique, Conseil et suivi pharmaceutique, Bonnes pratiques officinales, Pharmaco-économie
Programme component of Master's in Pharmacy (MONS) (day schedule)Faculty of Medicine, Pharmacy and Biomedical Sciences

CodeTypeHead of UE Department’s
contact details
Teacher(s)
UM-M2-PHARMA-002-MCompulsory UEPATRIS StéphanieM110 - Pharmacie Clinique
  • PATRIS Stéphanie
  • MARBAIX Sophie

Language
of instruction
Language
of assessment
HT(*) HTPE(*) HTPS(*) HR(*) HD(*) CreditsWeighting Term
  • Français
Français291600055.001st term

AA CodeTeaching Activity (AA) HT(*) HTPE(*) HTPS(*) HR(*) HD(*) Term Weighting
M-PCLI-201Pharmacie clinique et bonnes pratiques officinales240000Q1
M-PCLI-236Soins pharmaceutiques (conseil et suivi pharmaceutique)015000Q1
M-DOYM-237Pharmaco-économie51000Q1

Overall mark : the assessments of each AA result in an overall mark for the UE.
Programme component

Objectives of Programme's Learning Outcomes

Learning Outcomes of UE

At the end of this teaching unit based on lectures, discussions and simulations in an educational pharmacy, the student will be able to
- Apply the pharmaceutical care approach in community pharmacy and hospital pharmacy
- Provide patient-centered pharmaceutical care
- To check the adequacy of the treatment taking into account the characteristics of the patient
- To make choices taking into account the pharmaco-economy
- To conduct a support interview "Good Use of Medicines" 
- To adopt a quality approach (quality management, quality measurement, self-control, etc.)
- To carry out an medication review of the elderly patient with polypharmacy

UE Content: description and pedagogical relevance

Clinical pharmacy and good pharmacy practices
Pharmaceutical care (pharmaceutical advice and follow-up)
Pharmaco-economy

Prior Experience

Not applicable

Type(s) and mode(s) of Q1 UE assessment

  • Written examination - Face-to-face
  • Production (written work, report, essay, collection, product, etc.) - To be submitted online
  • Seminar participation - Face-to-face

Q1 UE Assessment Comments

Clinical pharmacy and good pharmacy practices:
written exam (open questions) which assesses the knowledge and ability to use the concepts seen in the course.
Pharmaceutical care (pharmaceutical advice and follow-up):
Presence at sessions at the pedagogical pharmacy and PC room (seminars) is compulsory. The student must count at least 75% of attendance at seminars. ANY absence must be justified. e-learning is compulsory
participation : 20%
reports / personal works: 80%
Pharmaco-economy:
Written work

Method of calculating the overall mark for the Q1 UE assessment

If all AAs have a score greater than or equal to 10/20:
Clinical pharmacy and good pharmacy practices; 5/9
Pharmaceutical care (pharmaceutical advice and follow-up): 3/9
Pharmaco-economy: 1/9

If at least one AA has a score below 10/20: the EU score will be the lowest AA score.

Type(s) and mode(s) of Q1 UE resit assessment (BAB1)

  • N/A - Néant

Q1 UE Resit Assessment Comments (BAB1)

not applicable

Method of calculating the overall mark for the Q1 UE resit assessment

not applicable

Type(s) and mode(s) of Q3 UE assessment

  • Written examination - Face-to-face
  • Production (written work, report, essay, collection, product, etc.) - To be submitted online
  • Seminar participation - Face-to-face

Q3 UE Assessment Comments

Clinical pharmacy and good pharmacy practices:
written exam (open questions) which assesses the knowledge and ability to use the concepts seen in the course.
Pharmaceutical care (pharmaceutical advice and follow-up):
Presence at sessions at the pedagogical pharmacy (seminars) is compulsory. The student must count at least 75% of attendance at seminars. ANY absence must be justified
participation (from Q1) : 20%
reports / personal works: 80%
Pharmaco-economy:
Written work 

Method of calculating the overall mark for the Q3 UE assessment

If all AAs have a score greater than or equal to 10/20:
Clinical pharmacy and good pharmacy practices; 5/9
Pharmaceutical care (pharmaceutical advice and follow-up): 3/9
Pharmaco-economy: 1/9

If at least one AA has a score below 10/20: the EU score will be the lowest AA score.

Type of Teaching Activity/Activities

AAType of Teaching Activity/Activities
M-PCLI-201
  • Cours magistraux
M-PCLI-236
  • Travaux pratiques
  • Etudes de cas
M-DOYM-237
  • Cours magistraux
  • Etudes de cas

Mode of delivery

AAMode of delivery
M-PCLI-201
  • Face-to-face
M-PCLI-236
  • Face-to-face
M-DOYM-237
  • Face-to-face

Required Learning Resources/Tools

AARequired Learning Resources/Tools
M-PCLI-201Documents on Moodle
M-PCLI-236Documents on Moodle
M-DOYM-237Not applicable

Recommended Learning Resources/Tools

AARecommended Learning Resources/Tools
M-PCLI-201Not applicable
M-PCLI-236Not applicable
M-DOYM-237Not applicable

Other Recommended Reading

AAOther Recommended Reading
M-PCLI-201Not applicable
M-PCLI-236Not applicable
M-DOYM-237Cleemput I, Neyt M, Van de Sande S, Thiry N. Belgian guidelines for economic evaluations and budget impact analyses : second edition. Health Technology Assessment (HTA) Brussels : Belgian Health Care Knowledge Centre (KCE) : 2012. KCE report 183C. D/212/10.273/54
(*) HT : Hours of theory - HTPE : Hours of in-class exercices - HTPS : hours of practical work - HD : HMiscellaneous time - HR : Hours of remedial classes. - Per. (Period), Y=Year, Q1=1st term et Q2=2nd term
Date de dernière mise à jour de la fiche ECTS par l'enseignant : 22/05/2025
Date de dernière génération automatique de la page : 14/03/2026
20, place du Parc, B7000 Mons - Belgique
Tél: +32 (0)65 373111
Courriel: info.mons@umons.ac.be